Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.60 +0.02 (+0.34%)
As of 03:54 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.26 billion
P/E Ratio
24.24
Consensus Rating
Strong Buy
Volume
10,832 shares
Average Volume
78,350 shares
Today's Range
$4.54
$4.61
Ultrapar Participacoes stock logo

2. Ultrapar Participacoes NYSE:UGP

$3.62 -0.03 (-0.68%)
Closing price 03:59 PM Eastern
Extended Trading
$3.63 +0.00 (+0.14%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$4.04 billion
P/E Ratio
8.06
Consensus Rating
Buy
Consensus Price Target
$3.20 (-11.7% Downside)
Volume
1.81 million shares
Average Volume
1.86 million shares
TuHURA Biosciences stock logo

3. TuHURA Biosciences NASDAQ:HURA

$2.59 -0.11 (-4.07%)
Closing price 04:00 PM Eastern
Extended Trading
$2.65 +0.06 (+2.32%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$129.63 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+389.1% Upside)
Volume
226,404 shares
Average Volume
305,268 shares
Today's Range
$2.55
$2.76
Senseonics stock logo

4. Senseonics NYSE:SENS

$0.45 -0.01 (-1.41%)
Closing price 04:00 PM Eastern
Extended Trading
$0.45 0.00 (0.00%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about Senseonics

Market Capitalization
$369.05 million
P/E Ratio
-3.48
Consensus Rating
Buy
Consensus Price Target
$1.54 (+239.4% Upside)
Volume
3.73 million shares
Average Volume
8.01 million shares
Climb Bio stock logo

5. Climb Bio NASDAQ:CLYM

$2.23 0.00 (0.00%)
As of 04:00 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$151.11 million
P/E Ratio
-3.19
Consensus Rating
Buy
Consensus Price Target
$9.00 (+303.6% Upside)
Volume
323,222 shares
Average Volume
355,737 shares
Western Copper & Gold stock logo

6. Western Copper & Gold NYSE:WRN

$1.46 +0.06 (+3.90%)
As of 09/2/2025

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$293.81 million
P/E Ratio
-73.25
Consensus Rating
Buy
Consensus Price Target
$4.00 (+173.0% Upside)
Volume
641,841 shares
Average Volume
377,719 shares
Immunic stock logo

7. Immunic NASDAQ:IMUX

$0.80 -0.02 (-2.56%)
Closing price 04:00 PM Eastern
Extended Trading
$0.79 -0.01 (-0.88%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$78.82 million
P/E Ratio
-0.85
Consensus Rating
Buy
Consensus Price Target
$7.50 (+838.7% Upside)
Volume
1.86 million shares
Average Volume
1.24 million shares
Hochschild Mining stock logo

8. Hochschild Mining OTCMKTS:HCHDF

$4.15 +0.29 (+7.38%)
As of 03:54 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$2.13 billion
Consensus Rating
Buy
Volume
102,426 shares
Average Volume
31,629 shares
Today's Range
$4.04
$4.15
50-Day Range
$3.34
$4.20
Rezolve AI stock logo

9. Rezolve AI NASDAQ:RZLV

$3.67 -0.07 (-1.87%)
Closing price 04:00 PM Eastern
Extended Trading
$3.71 +0.04 (+1.12%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$764.31 million
Consensus Rating
Buy
Consensus Price Target
$6.36 (+73.2% Upside)
Volume
17.62 million shares
Average Volume
7.21 million shares
Today's Range
$3.57
$3.92
Denison Mine stock logo

10. Denison Mine NYSEAMERICAN:DNN

$2.28 -0.04 (-1.72%)
Closing price 04:10 PM Eastern
Extended Trading
$2.28 0.00 (-0.22%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$2.04 billion
P/E Ratio
-38.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+31.6% Upside)
Volume
52.29 million shares
Average Volume
77.51 million shares
ImmunityBio stock logo

11. ImmunityBio NASDAQ:IBRX

$2.38 +0.04 (+1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$2.38 +0.00 (+0.21%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.25 billion
P/E Ratio
-4.96
Consensus Rating
Buy
Consensus Price Target
$10.75 (+351.7% Upside)
Volume
8.43 million shares
Average Volume
7.87 million shares
United States Antimony stock logo

12. United States Antimony NYSE:UAMY

$4.30 -0.25 (-5.38%)
Closing price 09/2/2025
Extended Trading
$4.33 +0.03 (+0.58%)
As of 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$535.23 million
P/E Ratio
-107.63
Consensus Rating
Buy
Consensus Price Target
$3.38 (-21.6% Downside)
Volume
4.44 million shares
Average Volume
4.08 million shares
Ur Energy stock logo

13. Ur Energy NYSEAMERICAN:URG

$1.37 -0.02 (-1.44%)
Closing price 04:10 PM Eastern
Extended Trading
$1.44 +0.08 (+5.47%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$499.82 million
P/E Ratio
-8.06
Consensus Rating
Buy
Consensus Price Target
$2.48 (+80.7% Upside)
Volume
7.42 million shares
Average Volume
5.37 million shares
Stardust Power stock logo

14. Stardust Power NASDAQ:SDST

$0.39 -0.01 (-3.26%)
Closing price 04:00 PM Eastern
Extended Trading
$0.39 +0.00 (+0.64%)
As of 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$32.86 million
P/E Ratio
-0.69
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,216.0% Upside)
Volume
422,098 shares
Average Volume
4.25 million shares
zSpace stock logo

15. zSpace NASDAQ:ZSPC

$1.98 -0.13 (-6.16%)
As of 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$47.22 million
Consensus Rating
Buy
Consensus Price Target
$10.00 (+405.1% Upside)
Volume
95,170 shares
Average Volume
72,311 shares
Today's Range
$1.97
$2.25
FibroBiologics stock logo

16. FibroBiologics NASDAQ:FBLG

$0.62 +0.03 (+5.30%)
Closing price 04:00 PM Eastern
Extended Trading
$0.62 0.00 (-0.71%)
As of 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$26.03 million
P/E Ratio
-1.73
Consensus Rating
Buy
Consensus Price Target
$13.00 (+1,992.1% Upside)
Volume
412,653 shares
Average Volume
345,240 shares
Mereo BioPharma Group stock logo

17. Mereo BioPharma Group NASDAQ:MREO

$1.77 +0.06 (+3.51%)
Closing price 04:00 PM Eastern
Extended Trading
$1.77 0.00 (0.00%)
As of 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$281.43 million
P/E Ratio
-25.29
Consensus Rating
Buy
Consensus Price Target
$7.40 (+318.1% Upside)
Volume
1.09 million shares
Average Volume
1.71 million shares
NRx Pharmaceuticals stock logo

18. NRx Pharmaceuticals NASDAQ:NRXP

$2.60 +0.28 (+12.07%)
Closing price 04:00 PM Eastern
Extended Trading
$2.62 +0.02 (+0.96%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$51.51 million
P/E Ratio
-1.16
Consensus Rating
Buy
Consensus Price Target
$28.50 (+996.2% Upside)
Volume
643,184 shares
Average Volume
506,772 shares
Quince Therapeutics stock logo

19. Quince Therapeutics NASDAQ:QNCX

$1.60 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.58 -0.03 (-1.56%)
As of 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$85.94 million
P/E Ratio
-1.47
Consensus Rating
Buy
Consensus Price Target
$8.14 (+408.9% Upside)
Volume
65,117 shares
Average Volume
230,830 shares
Perspective Therapeutics stock logo

20. Perspective Therapeutics NYSE:CATX

$3.32 -0.04 (-1.19%)
Closing price 04:00 PM Eastern
Extended Trading
$3.34 +0.03 (+0.75%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$246.55 million
Consensus Rating
Buy
Consensus Price Target
$12.56 (+278.2% Upside)
Volume
533,606 shares
Average Volume
925,413 shares
Today's Range
$3.30
$3.45
Black Diamond Therapeutics stock logo

21. Black Diamond Therapeutics NASDAQ:BDTX

$2.80 +0.05 (+1.82%)
Closing price 04:00 PM Eastern
Extended Trading
$2.85 +0.05 (+1.79%)
As of 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Black Diamond Therapeutics, Inc, a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. More about Black Diamond Therapeutics

Market Capitalization
$159.43 million
P/E Ratio
12.17
Consensus Rating
Buy
Consensus Price Target
$12.40 (+342.9% Upside)
Volume
743,243 shares
Average Volume
1.92 million shares
PolyPid stock logo

22. PolyPid NASDAQ:PYPD

$3.41 +0.06 (+1.79%)
Closing price 04:00 PM Eastern
Extended Trading
$3.38 -0.04 (-1.03%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. More about PolyPid

Market Capitalization
$54.22 million
P/E Ratio
-0.89
Consensus Rating
Buy
Consensus Price Target
$12.40 (+263.6% Upside)
Volume
97,671 shares
Average Volume
207,217 shares
Protara Therapeutics stock logo

23. Protara Therapeutics NASDAQ:TARA

$3.17 +0.05 (+1.60%)
Closing price 04:00 PM Eastern
Extended Trading
$3.18 +0.00 (+0.16%)
As of 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Protara Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. More about Protara Therapeutics

Market Capitalization
$122.30 million
P/E Ratio
-1.96
Consensus Rating
Buy
Consensus Price Target
$19.60 (+518.3% Upside)
Volume
95,712 shares
Average Volume
320,258 shares
Nuvation Bio stock logo

24. Nuvation Bio NYSE:NUVB

$2.94 -0.03 (-0.84%)
Closing price 03:59 PM Eastern
Extended Trading
$3.04 +0.10 (+3.40%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation Bio

Market Capitalization
$1.01 billion
P/E Ratio
-4.67
Consensus Rating
Buy
Consensus Price Target
$7.33 (+149.0% Upside)
Volume
3.05 million shares
Average Volume
4.25 million shares
atai Life Sciences stock logo

25. atai Life Sciences NASDAQ:ATAI

$4.59 +0.01 (+0.22%)
Closing price 04:00 PM Eastern
Extended Trading
$4.60 +0.01 (+0.22%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$983.82 million
P/E Ratio
-6.65
Consensus Rating
Buy
Consensus Price Target
$11.25 (+145.1% Upside)
Volume
3.27 million shares
Average Volume
3.82 million shares